Bailing Xu
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- PARP inhibition in cancer therapy
- Organic Chemistry top 10%
- Synthesis and biological activity
- Quinazolinone synthesis and applications
- Synthesis and Biological Evaluation
Papers in
-
- Signaling Pathways in Disease 13
- Biochemical and Molecular Research 8
- Cancer therapeutics and mechanisms 6
- Oncology 20
- PARP inhibition in cancer therapy 11
- Peptidase Inhibition and Analysis 9
- Co-authors
- Xiaoguang Chen (17 shared papers)Jie Zhou (22 shared papers)Xiaodong J. Wang (4 shared papers)Felicia A. Etzkorn (4 shared papers)Jing Jin (9 shared papers)Ming Ji (8 shared papers)Ran Cao (7 shared papers)Hailong Zhao (5 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry (9 papers)Journal of Medicinal Chemistry (7 papers)European Journal of Medicinal Chemistry (4 papers)Liquid Crystals (3 papers)ACS Medicinal Chemistry Letters (3 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Bailing Xu
51 papers receiving 915 citations
Peers
Comparison fields: 5 of 82
- Oncology 302
- Organic Chemistry 301
- Biological Psychiatry 22
- Immunology 169
- Molecular Biology 565
Countries citing papers authored by Bailing Xu
This map shows the geographic impact of Bailing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bailing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bailing Xu more than expected).
Fields of papers citing papers by Bailing Xu
This network shows the impact of papers produced by Bailing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bailing Xu. The network helps show where Bailing Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bailing Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 86 | |
| 2 | 2011 | 71 | |
| 3 | 2006 | 52 | |
| 4 | 2003 | 48 | |
| 5 | 2011 | 48 | |
| 6 | 2018 | 45 | |
| 7 | 2010 | 44 | |
| 8 | 2015 | 38 | |
| 9 | 2005 | 37 | |
| 10 | 2019 | 37 | |
| 11 | 2017 | 35 | |
| 12 | 2013 | 33 | |
| 13 | 2014 | 32 | |
| 14 | 2016 | 32 | |
| 15 | 2014 | 29 | |
| 16 | 2009 | 28 | |
| 17 | 2018 | 25 | |
| 18 | 2012 | 21 | |
| 19 | 2021 | 20 | |
| 20 | 2020 | 19 |
About Bailing Xu
Bailing Xu is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Immunology and Cellular and Molecular Neuroscience, having authored 53 papers that have together received 931 indexed citations. Recurring topics across this work include Signaling Pathways in Disease (13 papers), Toxin Mechanisms and Immunotoxins (11 papers), PARP inhibition in cancer therapy (11 papers), Peptidase Inhibition and Analysis (9 papers), Biochemical and Molecular Research (8 papers), Quinazolinone synthesis and applications (6 papers), Cancer therapeutics and mechanisms (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Oncology (302 citations), Organic Chemistry (301 citations), Biological Psychiatry (22 citations), Immunology (169 citations) and Molecular Biology (565 citations). Bailing Xu has collaborated with scholars based in China, United States and India. Frequent co-authors include Xiaoguang Chen, Jie Zhou, Xiaodong J. Wang, Felicia A. Etzkorn, Jing Jin, Ming Ji, Ran Cao, Hailong Zhao, Kimberly Wilson and Andrew T. Namanja. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Liquid Crystals and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.